Do you think another thing keeping GNBT pps down is the uncertainty of GNBT related things like Excellagen, Altucell, Regentys? The Covid news was good, but that is NuGenerex. Also, now that Covid numbers are up again, I'm guessing the VA/ Excellagen plan will slow those efforts again. We need to get a solid update on nearterm revenue with the telemedicine venture.

From Doc's comments, it looks like a limited time window for an NGIO listing by year's end. Perhaps they will do a CC if that happens.